tenapanor 50 MG Oral Tablet [Ibsrela]
- RxCUI
- 2199685
- RxNorm name
- tenapanor 50 MG Oral Tablet [Ibsrela]
- Display name
- tenapanor 50 MG Oral Tablet [Ibsrela]
- Full name
- tenapanor 50 MG Oral Tablet [Ibsrela]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:50
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| IBSRELA | TENAPANOR HYDROCHLORIDE | Ardelyx, Inc. | 2102da5f-a1a0-4ac7-a1f6-38698cf7273a | 2025-05-28 | Boxed warning, Warnings, Adverse reactions | 2199685 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 2102da5f-a1a0-4ac7-a1f6-38698cf7273a | tenapanor 50 MG Oral Tablet [Ibsrela] | SBD | 11 | These highlights do not include all the information needed to use IBSRELA ® safely and effectively. See full prescribing information for IBSRELA. IBSRELA (tenapanor) tablets, for oral use Initial U.S. Approval: 2019 | 20250528 |
| 2102da5f-a1a0-4ac7-a1f6-38698cf7273a | Ibsrela 50 MG Oral Tablet | SY | 11 | These highlights do not include all the information needed to use IBSRELA ® safely and effectively. See full prescribing information for IBSRELA. IBSRELA (tenapanor) tablets, for oral use Initial U.S. Approval: 2019 | 20250528 |
| 2102da5f-a1a0-4ac7-a1f6-38698cf7273a | Ibsrela 50 MG Oral Tablet | PSN | 11 | These highlights do not include all the information needed to use IBSRELA ® safely and effectively. See full prescribing information for IBSRELA. IBSRELA (tenapanor) tablets, for oral use Initial U.S. Approval: 2019 | 20250528 |